title: Praluent (Alirocumab)-Induced Renal Injury.
authors.affiliation: 1 Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center, Hofstra Northwell School of Medicine, Great Neck, NY, USA.
authors.forename: Kenar D
authors.initials: KD
authors.lastname: Jhaveri
authors.affiliation: 1 Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center, Hofstra Northwell School of Medicine, Great Neck, NY, USA.
authors.forename: Valerie S
authors.initials: VS
authors.lastname: Barta
authors.affiliation: 2 Department of Pathology, Montefiore Medical Center, Albert Einstein School of Medicine, New York, NY, USA.
authors.forename: James
authors.initials: J
authors.lastname: Pullman
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D007687:Kidney Tubules, Proximal / Q000473:pathology; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced / Q000150:complications / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C571059:alirocumab